Immunization; Infection Clinical Trial
Official title:
Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage: A Randomized Controlled Trial
Verified date | December 2017 |
Source | Interactive Research and Development |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Pakistan has one of the highest infant mortality rates in the world. One child in eleven dies
before their fifth birthday. In part, this is due to the low coverage rate of routine
childhood immunizations. Since Pakistan is a Low Middle Income Country (LMIC) it is essential
that an immunization intervention be developed that is suitable for its socioeconomic
setting. The tele-density of Pakistan exceeds 70% and the cost of SMS in Pakistan is very
low. Moreover the use of SMS in the country has broadened beyond the conventional use of
peer-peer chat to include social networking, SMS banking, delivery tracking, advertising,
business, disaster management, and identity verification. This study will utilise this
prevalence of mobile phones to assess whether simple and interactive sms reminders can serve
to increase childhood immunization coverage and timeliness.
The pilot study will be carried out only in 2 EPI (Extended program on Immunization) centers
at Korangi. The pilot will determine whether automated text messages produce increased
immunization coverage in the reminder groups compared to the control group. 656 participants
will be enrolled at Penta-1 and will be followed up until measles-2 vaccination. The results
of proposed pilot will provide the basis for a large scale-up study in urban and rural
settings in Pakistan.
Status | Completed |
Enrollment | 655 |
Est. completion date | March 8, 2014 |
Est. primary completion date | March 8, 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Weeks to 12 Weeks |
Eligibility |
Inclusion Criteria: - Child presenting for pentavalent 1- vaccine - Caregivers who owned a cellphone or had access to one - Caregivers permanently residing in Korangi Town, Karachi Exclusion Criteria: - Child presenting for a vaccine other than pentavalent -1 - Caregivers not having access to a cell phone - Caregivers residing outside of Korangi or planning to move from the catchment area |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Interactive Research and Development |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measles - 2 Completion | The primary outcome for the study is the proportion of infants completing measles 2 vaccine on schedule. | When the participants reach 2 years of age |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
Completed |
NCT04042246 -
Effect of Knowledge on Vaccine Take-up in Adamawa State, Northeastern Nigeria
|
N/A | |
Enrolling by invitation |
NCT05570630 -
VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination
|
N/A | |
Completed |
NCT03145324 -
Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
|
||
Recruiting |
NCT06185647 -
Evaluation in Practice of the Impact of NIrsevimab on EmeRgency Use for BRONCHIOlitis
|
||
Recruiting |
NCT05215327 -
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
|
Phase 2 | |
Completed |
NCT03355989 -
Evaluation of Conditional Cash Transfers (CCTs) for Immunization
|
N/A | |
Completed |
NCT02992925 -
Phase 3 Study of BK1310 in Healthy Infants
|
Phase 3 | |
Completed |
NCT03121638 -
Safety Study of NBP608 in Healthy Adult Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05171946 -
Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID-19 in Healthy Adults
|
Phase 1 | |
Completed |
NCT05661890 -
Seasonal Influenza and Pneumococcal Vaccination in the Elderly
|
||
Active, not recruiting |
NCT04444518 -
Increasing Influenza and Tdap Vaccination of Pregnant Women
|
N/A | |
Active, not recruiting |
NCT03908164 -
Optimising the Timing of Whooping Cough Immunisation in MUMs
|
Phase 4 | |
Not yet recruiting |
NCT03402646 -
Mobile Phone Reminders (and Photovoice) for Routine Immunization in Nigeria - The MOPING Study
|
N/A | |
Completed |
NCT04824638 -
BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers
|
Phase 2 | |
Recruiting |
NCT05774093 -
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
|
||
Completed |
NCT03083158 -
Immunity to Hepatitis B Vaccine
|
Phase 4 | |
Recruiting |
NCT04816760 -
Immune Cells Phenotypes During COVID-19
|
||
Completed |
NCT04870021 -
Hepatitis B Birth Dose for Newborns
|
Phase 4 | |
Completed |
NCT03519373 -
Pertussis Immunization During Pregnancy & HIV Infection
|